This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Daiichi Sankyo Company, Limited, Sankyo Company, Limited. Active years: 2003-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2012
Title: Kosaku Fujiwara: Innovator in Anti-Cancer Therapeutics
Introduction
Kosaku Fujiwara is a notable inventor based in Chofu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer treatments. With a total of 2 patents, his work focuses on innovative methods for treating various types of cancer.
Latest Patents
Fujiwara's latest patents include groundbreaking pharmaceutical compositions aimed at treating patients with cancer. One of his notable inventions is a method for treating individuals with carcinoma, sarcoma, or hematopoietic cancer. This method involves administering a compound of a specific formula alongside epidermal growth factor receptor (EGFR) inhibitors and vascular endothelial growth factor receptor (VEGFR) inhibitors. Additionally, he has developed a method for treating various cancers, including gastric, colon, lung, breast, pancreas, kidney, prostate, medulloblastoma, rhabdomyosarcoma, Ewing sarcoma, liposarcoma, multiple myeloma, and leukemia.
Another significant patent relates to therapeutic and prophylactic agents for neoplasms. This invention comprises a fused heterocyclic compound or a pharmaceutically acceptable salt as an active ingredient. It outlines the use of such compounds in preparing medicaments for the treatment and prevention of neoplasms, emphasizing the administration of a pharmaceutically effective amount to warm-blooded animals, preferably humans.
Career Highlights
Throughout his career, Kosaku Fujiwara has worked with prominent companies in the pharmaceutical industry, including Daiichi Sankyo Company, Limited and Sankyo Company, Limited. His experience in these organizations has contributed to his expertise in developing innovative cancer treatments.
Collaborations
Fujiwara has collaborated with notable colleagues, including Naomi Shimazaki and Shinichi Kurakata. These partnerships have likely enhanced his research and development efforts in the field of oncology.
Conclusion
Kosaku Fujiwara's contributions to anti-cancer therapeutics highlight his dedication to improving patient outcomes through innovative pharmaceutical solutions. His patents reflect a commitment to advancing cancer treatment methodologies, making him a significant figure in the field of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile